HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

AVTR

Avantor, Inc.

Healthcare — Medical Instruments & Supplies

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Hold 2.8 / 5 14 analysts
$15.04
$-0.02 (-0.10%)
Target: $14.56 (-3.1%)

Price History

52-Week Range
Sign in to add AVTR to a watchlist or set price alerts.

Fundamentals

Market Cap$9.32B
P/E Ratio (TTM)-
Forward P/E15.63
EPS (TTM)$-0.84
Dividend Yield-
Profit Margin-8.81%
Revenue Growth0.50%
ROE-9.70%
Debt/Equity65.68
Recommendation Hold 2.8
Analyst Target$14.56
Analysts14
Next Earnings Oct 28, 2026 BMO
Indexes -

Technical Indicators

RSI (14)77.4
Beta0.94
SMA 20$11.41
SMA 40$10.56
52-Week High$15.93
52-Week Low$7.27
50-Day Avg$10.17
200-Day Avg$10.23
Avg Volume$10.62M
Volume$10.84M

Performance Analysis

NEUTRAL

AVTR presents a mixed picture with both positive and negative indicators.

+ Showing strength at 90% of its 52-week range.
- RSI at 77.4 indicates overbought conditions — a pullback may be due.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
~ Modest revenue growth of 0.5% year-over-year.
- Operating at a loss with -8.8% margin.
~ Wall Street consensus is "Hold" from 14 analysts.
- Average analyst target of $14.56 implies 3.1% downside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Aug 01, 2026 04:14 UTC

Back to Screener Export Report